ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen.

Sieuwerts, Anieta M; Inda, Márcia A; Smid, Marcel; van Ooijen, Henk; van de Stolpe, Anja; Martens, John W M; Verhaegh, Wim F J

Sieuwerts, Anieta M; Inda, Márcia A; Smid, Marcel; van Ooijen, Henk; van de Stolpe, Anja; Martens, John W M; Verhaegh, Wim F J.

Afiliação

Sieuwerts AM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Inda MA; Philips Research, Precision Diagnostics Department, High Tech Campus 11, 5656 AE Eindhoven, The Netherlands.
Smid M; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
van Ooijen H; Philips Research, Precision Diagnostics Department, High Tech Campus 11, 5656 AE Eindhoven, The Netherlands.
van de Stolpe A; Philips Research, Precision Diagnostics Department, High Tech Campus 11, 5656 AE Eindhoven, The Netherlands.
Martens JWM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Verhaegh WFJ; Philips Research, Precision Diagnostics Department, High Tech Campus 11, 5656 AE Eindhoven, The Netherlands.

Cancers (Basel) ; 12(4)2020 Mar 27.

Article em En | MEDLINE | ID: mdl-32230714